Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Debt Ratio of 0.05 for Q1 2026, up 46.17% year-over-year from 0.03 in Q1 2025, and up 20.14% quarter-over-quarter from 0.04 in Q4 2025.
Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2013 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Debt Ratio history runs 12 years deep, the most recent figure standing at 0.05 for Q1 2026.
- In Q1 2026, Debt Ratio rose 46.17% year-over-year to 0.05; the TTM figure through Mar 2026 stood at 0.05 (up 46.17% YoY), while the FY2025 annual figure was 0.04, changed N/A from the prior year.
- Debt Ratio for Q1 2026 stood at 0.05, up from 0.04 in the prior quarter.
- The five-year high for Debt Ratio was 0.06 in Q3 2023, with the low at 0.01 in Q3 2022.
- The 5-year median for Debt Ratio is 0.03 (2024), against an average of 0.03.
- The sharpest annual moves came in 2023 and 2024: Debt Ratio soared 481.03% in 2023, then tumbled 56.3% in 2024.
- Viridian Therapeutics, Inc.\DE's Debt Ratio stood at 0.01 in 2022, then jumped by 285.91% to 0.04 in 2023, then sank by 35.47% to 0.03 in 2024, then soared by 43.2% to 0.04 in 2025, then gained by 20.14% to 0.05 in 2026.
- Business Quant data shows VRDN's Debt Ratio at 0.05 in Q1 2026, 0.04 in Q4 2025, and 0.04 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | 0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.10 |
| Mar 31, 2026 | 0.05 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.03 |
| Sep 30, 2020 | 0.13 |
| Jun 30, 2020 | 0.16 |
| Mar 31, 2020 | 0.09 |
| Dec 31, 2019 | 0.14 |